Medical injection molded plastics are used in the manufacturing of various medical devices and components, such as syringes, vials, IV components, and other disposable medical products. These plastics are designed to meet strict regulatory and quality standards to ensure safety and reliability in medical applications. The injection molding process allows for the production of complex and precise parts with high consistency and efficiency, making it well-suited for medical device manufacturing. Medical injection molded plastics play a crucial role in modern healthcare by providing cost-effective and high-quality solutions for a wide range of medical needs.

According to the latest estimates, the global medical injection molded plastics market is set to achieve an incremental growth of USD 7.4 billion, accelerating at a CAGR of almost 4.4% during the forecast period 2023-2029.

This comprehensive industry report provides market estimates and forecasts, accompanied by a detailed examination of the product, application, and region aspects. It delivers a quantitative analysis of the market, empowering stakeholders to leverage existing market opportunities. Furthermore, the report identifies key segments for potential opportunities and strategies, drawing insights from market trends and the approaches of leading competitors.

The global baby bottle market has been extensively analyzed by categorizing it according to various sub-segments in order to provide accurate forecasts of industry size and assess trends within specific areas.
The global market for medical injection molded plastics can be segmented by product: acrylonitrile butadiene styrene (ABS), polycarbonate (PC), polyethylene (PE), polypropylene (PP), polystyrene (PS), others. The PP segment captured the largest share of the market in 2022.
Medical injection molded plastics market is further segmented by application: cleanroom supplies, implants, medical components, mobility aids, others. The medical components segment held the largest share of the global medical injection molded plastics market in 2022 and is anticipated to hold its share during the forecast period.
Based on region, the medical injection molded plastics market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2022, North America made up the largest share of revenue generated by the medical injection molded plastics market.

The report also provides a detailed analysis of several leading medical injection molded plastics market vendors that include Arkema S.A., Covestro AG, Dow Inc., Eastman Chemical Company, Evonik Industries AG, Ineos Group Limited, Saudi Basic Industries Corporation (SABIC), Sumitomo Chemical Co., Ltd., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Why Choose This Report

Gain a reliable outlook of the global medical injection molded plastics market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Market Segments Covered in Global Medical Injection Molded Plastics Industry Analysis:
i.) Product
– Acrylonitrile butadiene styrene (ABS)
– Polycarbonate (PC)
– Polyethylene (PE)
– Polypropylene (PP)
– Polystyrene (PS)
– Others

ii.) Application
– Cleanroom supplies
– Implants
– Medical components
– Mobility aids
– Others

iii.) Region
– North America
– Europe
– Asia-Pacific
– MEA (Middle East and Africa)
– Latin America